Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Roche Suspends Medicines Deliveries To Indebted Greek Hospitals

This article was originally published in The Pink Sheet Daily

Executive Summary

Mired in economic troubles, Greece's public hospitals owe the drug maker more than €150 million. The health ministry says it is sending cash soon.

You may also be interested in...

German HTA Blueprint Could Be Imposed On Greece

Germany’s role in preparing a health reform agreement between Greece and the World Health Organization may lead to a G-BA/IQWiG-style HTA process being introduced in the Hellenic Republic.

Greece, Slashing Drug Budget Via Cuts And Non-Payment, Backs Generics

Greece has slashed its pharmaceutical budget in half by price cuts and withholding payments, but it is now turning to generics to fulfill its citizens’ health care needs.

Greece Looks For Savings Of €1.25 Billion On Drug Spending In 2011

Electronic prescribing, the promotion of generics and the monitoring of doctors' prescribing are some of the measures to be included to reduce spending on medicines next year.


Latest News



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts